433 related articles for article (PubMed ID: 16493063)
1. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of α-defensin human neutrophil peptides on neutrophil apoptosis.
Nagaoka I; Suzuki K; Murakami T; Niyonsaba F; Tamura H; Hirata M
Int J Mol Med; 2010 Dec; 26(6):925-34. PubMed ID: 21042789
[TBL] [Abstract][Full Text] [Related]
3. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
[TBL] [Abstract][Full Text] [Related]
4. Modulation of neutrophil apoptosis by antimicrobial peptides.
Nagaoka I; Suzuki K; Niyonsaba F; Tamura H; Hirata M
ISRN Microbiol; 2012; 2012():345791. PubMed ID: 23724322
[TBL] [Abstract][Full Text] [Related]
5. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1.
Christenson K; Björkman L; Tängemo C; Bylund J
J Leukoc Biol; 2008 Jan; 83(1):139-48. PubMed ID: 17962368
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of human beta-defensins on neutrophil apoptosis.
Nagaoka I; Niyonsaba F; Tsutsumi-Ishii Y; Tamura H; Hirata M
Int Immunol; 2008 Apr; 20(4):543-53. PubMed ID: 18308714
[TBL] [Abstract][Full Text] [Related]
8. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
[TBL] [Abstract][Full Text] [Related]
9. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.
Elssner A; Duncan M; Gavrilin M; Wewers MD
J Immunol; 2004 Apr; 172(8):4987-94. PubMed ID: 15067080
[TBL] [Abstract][Full Text] [Related]
10. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors.
Tjabringa GS; Ninaber DK; Drijfhout JW; Rabe KF; Hiemstra PS
Int Arch Allergy Immunol; 2006; 140(2):103-12. PubMed ID: 16557028
[TBL] [Abstract][Full Text] [Related]
11. The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.
Braun BJ; Slowik A; Leib SL; Lucius R; Varoga D; Wruck CJ; Jansen S; Podschun R; Pufe T; Brandenburg LO
J Neuroinflammation; 2011 Feb; 8(1):11. PubMed ID: 21299846
[TBL] [Abstract][Full Text] [Related]
12. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
[TBL] [Abstract][Full Text] [Related]
13. The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway.
Singh D; Qi R; Jordan JL; San Mateo L; Kao CC
J Biol Chem; 2013 Mar; 288(12):8258-8268. PubMed ID: 23386607
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis.
Tripathi S; Wang G; White M; Rynkiewicz M; Seaton B; Hartshorn K
PLoS One; 2015; 10(8):e0133454. PubMed ID: 26308522
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.
Kim Y; Lee BD; Kim O; Bae YS; Lee T; Suh PG; Ryu SH
J Immunol; 2006 Mar; 176(5):2969-75. PubMed ID: 16493055
[TBL] [Abstract][Full Text] [Related]
16. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
17. LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils.
Lee HY; Kim SD; Shim JW; Lee SY; Yun J; Bae YS
Exp Mol Med; 2009 May; 41(5):325-33. PubMed ID: 19307752
[TBL] [Abstract][Full Text] [Related]
18. FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast.
Iaccio A; Cattaneo F; Mauro M; Ammendola R
Arch Biochem Biophys; 2009 Jan; 481(1):94-100. PubMed ID: 18996352
[TBL] [Abstract][Full Text] [Related]
19. LL-37-mediated activation of host receptors is critical for defense against group A streptococcal infection.
Biswas D; Ambalavanan P; Ravins M; Anand A; Sharma A; Lim KXZ; Tan RYM; Lim HY; Sol A; Bachrach G; Angeli V; Hanski E
Cell Rep; 2021 Mar; 34(9):108766. PubMed ID: 33657368
[TBL] [Abstract][Full Text] [Related]
20. LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.
Yu Y; Zhang Y; Zhang Y; Lai Y; Chen W; Xiao Z; Zhang W; Jin M; Yu B
Int Immunopharmacol; 2017 Aug; 49():6-12. PubMed ID: 28549244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
